Digital Health Startup, Real Time Touch releases 4 new videos on the benefits and use cases of its RemoteRx telemedicine platform.

New group to focus efforts on greater patient access to trial sponsors to bring new therapies to market more safely and sooner.

Film Release Coincides with 2017 Clinical Trials Awareness Week

Xperii is looking for people interested in helping advance scientific research in New England through paid opportunities.

Media Host, Community Leader, Business Man And Author Al Wynn Changes Media Show Name

According to PBI, the major increase in the number of diagnosed cases of type 2 diabetes is the fastest-growing fraction in all age groups, and medical expenses for people with diabetes are more than two times higher than for people without diabetes.

Vice President of R&D Singled Out For Work In Seeking Clues to Heart-Disease Risk

The article, titled "Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles," will appear in the March 1 issue of The Journal of Infectious Diseases.

Chuck Panozzo has joined forces with Atlanta-based biotech firm GeoVax Labs as a spokesperson for the company's HIV/AIDS vaccines, currently in clinical trials. The partnership crystallized after Panozzo met GeoVax's lead scientist.

The Study Chair will be Dr. David E. Cohn of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

People with high levels of "good cholesterol," HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers recently reported.

Quit Tea LLC posted some of the initial trial results online. They can be found at http://quittea.com/blog/?page_id=160 and will be updated as the trial progresses. Highlight, 80% of respondents report feeling "less desire to smoke" after Quit Tea.

MENA - CRC has an extensive experience interfacing with European, North American, and Middle Eastern central and local Ethics Committees, Institutional Review Boards (IRB) and the Ministries of Health and can provide Phase I, II, III and IV